碳青霉烯类限制对ICU铜绿假单胞菌药敏的影响
该回顾性两阶段研究在成人ICU比较碳青霉烯类限制前后铜绿假单胞菌药敏,发现限制后碳青霉烯类消耗量从28.44降至11.67 DDDs/1000患者日(P=0.012),对亚胺培南和美罗培南耐药率分别从76.0%降至38.5%(P=0.019)和从74.1%降至30.0%(P=0.012),其他抗菌药物敏感性未受影响。
要点
- 碳青霉烯类限制后ICU铜绿假单胞菌对亚胺培南和美罗培南耐药率显著下降。
- 碳青霉烯类消耗量从28.44降至11.67 DDDs/1000患者日(P=0.012)。
- 其他抗菌药物对铜绿假单胞菌的敏感性未受碳青霉烯类限制影响。
核心结论
- 短期限制碳青霉烯类可能有效管理铜绿假单胞菌对碳青霉烯类的耐药问题。
研究设计与样本
- 成人ICU两阶段回顾性研究,第一阶段为2016年5月至7月(限制前),第二阶段为2016年9月至11月(实施限制期间)。
主要发现
- 碳青霉烯类总消耗量从28.44降至11.67 DDDs/1000患者日(P=0.012)。
- 铜绿假单胞菌对亚胺培南耐药率从76.0%降至38.5%(P=0.019)。
- 铜绿假单胞菌对美罗培南耐药率从74.1%降至30.0%(P=0.012)。
- 铜绿假单胞菌对其他抗菌药物的敏感性未受碳青霉烯类限制影响。
关键数值与推荐
- 碳青霉烯类耐药铜绿假单胞菌的衡量指标为耐药分离株比例(耐药百分比)。
- 抗菌药物消耗量衡量指标为DDDs/1000患者日。
临床怎么用
- 在ICU中实施碳青霉烯类限制可作为应对铜绿假单胞菌碳青霉烯类耐药的策略之一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rates of carbapenem-resistant Pseudomonas aeruginosa are increasing. Aggressive prevention strategies, including instituting antimicrobial stewardship programmes, are essential for combating antimicrobial resistance. OBJECTIVES: We conducted this study to compare the antimicrobial susceptibility pattern of P. aeruginosa before and after carbapenem restriction. METHODS: We conducted a two-phase retrospective study in an adult ICU. The first phase was from May until July 2016 (before carbapenem restriction), whereas the second phase was from September until November 2016 (while implementing carbapenem restriction). The antimicrobial susceptibility pattern of P. aeruginosa was reviewed in August and December 2016. The measure of carbapenem-resistant P. aeruginosa was the proportion of resistant isolates (percentage resistant). The measure of antibacterial consumption in the study phases was DDDs/1000 patient days. RESULTS: The overall carbapenem consumption decreased significantly in the second phase, from 28.44 to 11.67 DDDs/1000 patient days (P = 0.012). The resistance of P. aeruginosa to imipenem and meropenem decreased significantly from 76.0% to 38.5% (P = 0.019) and from 74.1% to 30.0% (P = 0.012), respectively. Susceptibility of P. aeruginosa to other antibacterials was not affected by carbapenem restriction. CONCLUSIONS: These data suggest that restricting carbapenems, even for a short duration, may be an effective strategy for managing the problem of carbapenem resistance in P. aeruginosa.
引用
- Abdallah M, Badawi M, Amirah MF, et al. Impact of carbapenem restriction on the antimicrobial susceptibility pattern of Pseudomonas aeruginosa isolates in the ICU. J Antimicrob Chemother. 2017. PMID: 28961733. doi:10.1093/jac/dkx273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。